Title : miR-221 confers lapatinib resistance by negatively regulating p27kip1 in HER2-positive breast cancer.

Pub. Date : 2021 Oct

PMID : 34382727






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Development of acquired resistance to lapatinib, a dual EGFR/HER2 tyrosine kinase inhibitor, severely limited the duration of clinical response in advanced HER2-driven breast cancer patients. Lapatinib epidermal growth factor receptor Homo sapiens